Research

Medical Sciences

Title :

Aerosolized smart nanocomposites for the treatment of drug resistant Tuberculosis

Area of research :

Medical Sciences

Focus area :

Science & Engineering Research Board - Empowerment & Equity Opportunities for Excellence in Science (SERB-EMEQ)

Principal Investigator :

Dr. C. Singh Associate Professor I.S.F. College of Pharmacy NH 95, Ghal Kalan Punjab

Timeline Start Year :

2020

Timeline End Year :

2021

Details

Total Budget (INR):

 37,54,456

Organizations involved

Implementing Agency :

 I.S.F. College of Pharmacy Punjab

Funding Agency :

 Department of Science and Technology (DST)

Related Research

A combined approach of structure based drug design & drug re-purposing strategy for the discovery of small molecules as inhibitors of Mycobacterium Tuberculosis mmpL3
A combined approach of structure based drug design & drug re-purposing strategy for the discovery of small molecules as inhibitors of Mycobacterium Tuberculosis mmpL3
A Novel Herbal Product for Vulvovaginal Candidiasis
Aldosterone bloCkade for Health Improvement EValuation in End-stage renal disease (ACHIEVE)
An event-driven, phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficiency, safety, immunogenicity, & lot-to-lot consistency of Bbv152, a whole-varion inactivated Sars-Cov-2 vaccine in adults more than 18 to years of age